Susquehanna International Group
PLXP

Susquehanna International Group’s PLx Pharma Inc. Common Stock PLXP Stock Holding History

Susquehanna International Group’s Portfolio PLXP Stock Details PLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-14,500
Closed -$2.32K – 13984
2022
Q4 		$2.32K Sell
14,500
-10,600
-42% -$4.44K ﹤0.01% 12120
2022
Q3 		$16K Sell
25,100
-23,800
-49% -$35.1K ﹤0.01% 12689
2022
Q2 		$119K Sell
48,900
-62,900
-56% -$175K ﹤0.01% 11295
2022
Q1 		$452K Buy
111,800
+24,200
+28% +$133K ﹤0.01% 9232
2021
Q4 		$702K Sell
87,600
-176,800
-67% -$2.07M ﹤0.01% 8250
2021
Q3 		$5.1M Buy
264,400
+198,700
+302% +$3.47M ﹤0.01% 3922
2021
Q2 		$907K Buy
+65,700
New +$778K ﹤0.01% 8037

Other funds holding PLXP

SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
BBA
Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return

Susquehanna International Group's PLXP Position: Q2 2023 in Review

Susquehanna International Group sold out of PLx Pharma Inc. Common Stock (PLXP) in Q2 2023, closing a stake of 52,728 shares — an estimated $6.86K sold.

Susquehanna International Group first reported a position in PLXP in Q2 2017 and held it in 11 quarters. The position peaked at $3.3M in Q3 2021. 4 funds tracked by Wall St. Rank hold PLXP as of Q2 2023.

  • Susquehanna International Group reported no remaining PLx Pharma Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Susquehanna International Group sold 52,728 PLx Pharma Inc. Common Stock shares in Q2 2023, an estimated $6.86K.
  • Susquehanna International Group first reported a position in PLx Pharma Inc. Common Stock in Q2 2017 and held it in 11 quarters.
  • Susquehanna International Group's PLx Pharma Inc. Common Stock position peaked at $3.3M in Q3 2021.
  • 4 funds tracked by Wall St. Rank held PLx Pharma Inc. Common Stock as of Q2 2023.

Based on Susquehanna International Group's 13F filing for Q2 2023, filed 11 Aug 2023.